Literature DB >> 2936448

Immune surveillance and natural resistance: an evaluation.

W Den Otter.   

Abstract

Concepts in tumour immunology are changing fundamentally. Around 1970 tumour immunology contained the following related concepts: Thousands of tumour cells arise de novo each day. Tumour cells are antigenic in their host. All these antigenic tumour cells are killed by a strong immune surveillance system. A more likely set of concepts looks as follows: Tumour cells do not arise frequently. Tumour cells may be antigenic or not. There is no need to postulate a very strong immune surveillance or natural resistance system. In this paper I am reviewing our present knowledge of immune surveillance and natural resistance. Only scanty information appears to be available. This information suggests that virally induced tumours are usually killed by cytotoxic T lymphocytes, and natural killer cells, whereas immune surveillance and natural resistance against other tumours may be quite weak.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936448     DOI: 10.1007/bf00199854

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  93 in total

1.  Antibody-dependent cellular cytotoxicity against tumor cells. II. The promonocyte identified as effector cell.

Authors:  W Domzig; M L Lohmann-Matthes
Journal:  Eur J Immunol       Date:  1979-04       Impact factor: 5.532

2.  Therapy with allogeneic immune peritoneal cells.

Authors:  H F Dullens; W Den Otter
Journal:  Cancer Res       Date:  1974-07       Impact factor: 12.701

Review 3.  The concept of immunological surveillance.

Authors:  F M Burnet
Journal:  Prog Exp Tumor Res       Date:  1970

4.  Enhanced NK cell activity in mice injected with interferon and interferon inducers.

Authors:  M Gidlund; A Orn; H Wigzell; A Senik; I Gresser
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

5.  Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene-induced sarcomas.

Authors:  R Evans; E M Lawler
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

6.  Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors.

Authors:  H T Holden; J S Haskill; H Kirchner; R B Herberman
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

7.  In vitro antibody-dependent cellular cytotoxicity against human T-cell leukemia/lymphoma virus (HTLV)-producing cells.

Authors:  H Miyakoshi; H Koide; T Aoki
Journal:  Int J Cancer       Date:  1984-03-15       Impact factor: 7.396

8.  Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model.

Authors:  R J De Boer; P Hogeweg; H F Dullens; R A De Weger; W Den Otter
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

9.  Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ.

Authors:  M Introna; P Allavena; A Biondi; N Colombo; A Villa; A Mantovani
Journal:  J Natl Cancer Inst       Date:  1983-01       Impact factor: 13.506

10.  Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice.

Authors:  N Minato; B R Bloom; C Jones; J Holland; L M Reid
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

View more
  14 in total

1.  An explanation for the worsened prognosis in some cancer patients of perioperative transfusion: the time-dependent release of biologically active growth factors from stored blood products.

Authors:  Tahwinder Upile; Waseem Jerjes; Jaspal Mahil; Navdeep Upile; Holger Sudhoff; Anthony Wright; Colin Hopper
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-24       Impact factor: 2.503

2.  Immune surveillance and natural resistance: an evaluation.

Authors:  M L Kripke
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.

Authors:  H F Dullens; W Vuist; M Van der Maas; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 4.  [New knowledge on immunology in gynecologic cancer].

Authors:  R Kreienberg
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

5.  T-cell surface molecules involved in the induction and expression of lymphokine-activated killing of autologous and allogeneic tumor targets.

Authors:  A L Nashed; B Mukherji
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

6.  Increased bleomycin-induced chromosome damage in lymphocytes of patients with common variable immunodeficiency indicates an involvement of chromosomal instability in their cancer predisposition.

Authors:  I Vorechovsky; M Munzarova; J Lokaj
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Lack of a relationship between immune function and chemically induced hepatocarcinogenesis in B6C3F1 mice.

Authors:  D R Germolec; R R Maronpot; M F Ackermann; S J Vore; K Dittrich; G J Rosenthal; M I Luster
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 8.  New insights into tumor-host interactions in lymphoma metastasis.

Authors:  V Umansky; V Schirrmacher; M Rocha
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

9.  A survey of some formal models in tumor immunology.

Authors:  H F Dullens; M W Van der Tol; R A De Weger; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Incidence and growth of methylcholanthrene-induced tumors in mice with altered immunological status.

Authors:  C Trutin-Ostović; M Golubić; M Matović; M Marusić
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.